These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12192306)
1. Regulation of plasminogen activator inhibitor-1 secretion by growth factors in smooth muscle cells. Lau HK; Ho J Blood Coagul Fibrinolysis; 2002 Sep; 13(6):541-9. PubMed ID: 12192306 [TBL] [Abstract][Full Text] [Related]
2. Regulation of plasminogen activator inhibitor-1 secretion by urokinase and tissue plasminogen activator in rat epithelioid-type smooth muscle cells. Lau HK; Ho J Br J Haematol; 2002 Apr; 117(1):151-8. PubMed ID: 11918547 [TBL] [Abstract][Full Text] [Related]
3. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks. Samarakoon R; Higgins PJ J Cell Sci; 2002 Aug; 115(Pt 15):3093-103. PubMed ID: 12118065 [TBL] [Abstract][Full Text] [Related]
4. Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Takeda K; Ichiki T; Tokunou T; Iino N; Fujii S; Kitabatake A; Shimokawa H; Takeshita A Arterioscler Thromb Vasc Biol; 2001 May; 21(5):868-73. PubMed ID: 11348889 [TBL] [Abstract][Full Text] [Related]
5. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes. Lau HK Cardiovasc Res; 1999 Sep; 43(4):1049-59. PubMed ID: 10615432 [TBL] [Abstract][Full Text] [Related]
6. Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells. Watanabe A; Kurabayashi M; Arai M; Sekiguchi K; Nagai R Cardiovasc Res; 2001 Jul; 51(1):151-9. PubMed ID: 11399257 [TBL] [Abstract][Full Text] [Related]
7. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337 [TBL] [Abstract][Full Text] [Related]
13. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways. Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327 [TBL] [Abstract][Full Text] [Related]
14. Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors. Kenagy RD; Clowes AW Thromb Res; 1995 Jan; 77(1):55-61. PubMed ID: 7701477 [TBL] [Abstract][Full Text] [Related]
15. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. Nicholl SM; Roztocil E; Davies MG J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933 [TBL] [Abstract][Full Text] [Related]
16. Characterization of platelet-derived growth factor-induced p38 mitogen-activated protein kinase activation in vascular smooth muscle cells. Yamaguchi H; Igarashi M; Hirata A; Tsuchiya H; Susa S; Tominaga M; Daimon M; Kato T Eur J Clin Invest; 2001 Aug; 31(8):672-80. PubMed ID: 11473568 [TBL] [Abstract][Full Text] [Related]
17. Impact of lysophosphatidylcholine on the plasminogen activator system in cultured vascular smooth muscle cells. Yoon BK; Kang YH; Oh WJ; Park K; Lee DY; Choi D; Kim DK; Lee Y; Rhyu MR J Korean Med Sci; 2012 Jul; 27(7):803-10. PubMed ID: 22787379 [TBL] [Abstract][Full Text] [Related]
18. Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G/5G polymorphism of the PAI-1 gene. Nordt TK; Eschenfelder E; Peter K; Sobel BE; Bode C Thromb Haemost; 2003 Jul; 90(1):36-42. PubMed ID: 12876623 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020 [TBL] [Abstract][Full Text] [Related]
20. TAS-301 blocks receptor-operated calcium influx and inhibits rat vascular smooth muscle cell proliferation induced by basic fibroblast growth factor and platelet-derived growth factor. Sasaki E; Nozawa Y; Miyoshi K; Kanda A; Yamasaki Y; Miyake H; Matsuura N Jpn J Pharmacol; 2000 Nov; 84(3):252-8. PubMed ID: 11138725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]